SQUAWK/NEWS
Account
Account
Menu
Live News EQUITY FLASH M impact

DGX Gets NY Approval

Quest Diagnostics receives New York's Department of Health's approval for its Haystack Minimal Residual Disease liquid biopsy test

DGX

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.